Atrial natriuretic peptide and cyclic guanosine-monophosphate in children and adolescents on peritoneal dialysis

Clin Nephrol. 1994 Jul;42(1):50-3.

Abstract

Plasma concentrations of atrial natriuretic peptide (ANP) and its second messenger cyclic guanosine-monophosphate (cGMP) were studied in 28 children and adolescents (1 to 19 years) on peritoneal dialysis and compared to 55 healthy children (1 to 20 years). Dialysate concentrations of the hormones were measured also in the patients. Plasma ANP was not significantly different in patients and controls (28.8 pmol/l [15.5-53.6 pmol/l] [median, lower and upper quartile] versus 26.3 pmol/l [19.9-31.8 pmol/l]). In seven children on peritoneal dialysis it exceeded an upper normal limit of 50 pmol/l, but it fell to normal values in four of them after forced fluid withdrawal. Plasma cGMP was elevated in the patients compared to the control children (1.6 nmol/l [1.1-1.7 nmol/l] versus 1.0 nmol/l [0.8-1.2 nmol/l]; p < 0.05). There were only weak correlations between plasma and dialysate concentrations of ANP and cGMP. Plasma concentrations of ANP seem to be elevated in children on peritoneal dialysis in case of fluid overload.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Atrial Natriuretic Factor / analysis
  • Atrial Natriuretic Factor / blood*
  • Child
  • Cyclic GMP / analysis
  • Cyclic GMP / blood*
  • Female
  • Humans
  • Kidney Failure, Chronic / blood
  • Kidney Failure, Chronic / therapy*
  • Male
  • Peritoneal Dialysis*
  • Peritoneal Dialysis, Continuous Ambulatory*
  • Radioimmunoassay
  • Reference Values
  • Water-Electrolyte Imbalance / blood*

Substances

  • Atrial Natriuretic Factor
  • Cyclic GMP